DC PHARMA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

DC PHARMA Trademark

Serial Number: 79366207 • Registration: 7423994

DC PHARMA is a trademark filed by YANTAI DONGCHENG BIOCHEMICALS CO., LTD. on February 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

YANTAI DONGCHENG BIOCHEMICALS CO., LTD. (3 trademarks)

No. 7, Changbaishan Road,

Entity Type: 99

Trademark Details

Filing Date

February 10, 2023

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Diagnostic radiopharmaceutical preparations; vitamin tablets; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, oncological diseases, cardiovascular and cerebrovascular diseases, colds, cough, influenza, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; biochemical medicines for the treatment of cancer; liquid herbal supplements; medicinal drinks; capsules sold empty for pharmaceuticals; pharmaceutical preparations, namely, antivirals; radioactive substances for medical purposes; pharmaceutical preparations for treating chemical imbalances; mixed biological preparations for the prevention and treatment of infectious diseases; isotopes for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; injectable pharmaceuticals for treatment of anaphylactic reactions; medicines made of Chinese traditional medicinal herbs; dietary supplements

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2024 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Dec 11, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 10, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 16, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2024 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 28, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 22, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 6, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 30, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2023 REPR